Normalizing ELISPOT to quantify human cytomegalovirus (HCMV) and Epstein Barr-virus (EBV) specific T-cell response in kidney transplant recipients

被引：0
|
作者：
Fornara, C. [1 ]
Cassaniti, I. [1 ]
Calarota, S. A. [1 ]
Adzasehoun, K. M. G. [1 ]
Scaramuzzi, L. [2 ]
Comolli, G. [3 ]
Baldanti, F. [1 ,4 ]
机构：
[1] Fdn IRCCS Policlin San Matteo, Mol Virol Unit, Microbiol & Virol Dept, Pavia, Italy
[2] Fdn IRCCS Policlin San Matteo, Nephrol Dialysis & Transplantat Unit, Pavia, Italy
[3] Fdn IRCCS Policlin San Matteo, Mol Virol Unit, Microbiol & Virol Dept, Biotechnol Area,Expt Res Labs, Pavia, Italy
[4] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, I-27100 Pavia, Italy
来源：
JOURNAL OF CLINICAL VIROLOGY | 2016年 / 82卷
关键词：
D O I：
10.1016/j.jcv.2016.08.197
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
259
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 50 条
  • [21] Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli
    Gabanti, Elisa
    Bruno, Francesca
    Scaramuzzi, Lucia
    Mangione, Filippo
    Zelini, Paola
    Gerna, Giuseppe
    Lilleri, Daniele
    NEW MICROBIOLOGICA, 2016, 39 (04): : 247 - 258
  • [22] Monitoring of cytomegalovirus, Epstein-Barr virus and adenovirus infections in hematopoietic stem cell transplant recipients
    Seflek, Buket
    Gumus, Hatice Hale
    Cimentepe, Mehmet
    Kupeli, Serhan
    Yarkin, Fugen
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (02): : 432 - 440
  • [23] Syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma
    Kanegane, H
    Bhatia, K
    Gutierrez, M
    Kaneda, H
    Wada, T
    Yachie, A
    Seki, H
    Arai, T
    Kagimoto, S
    Okazaki, M
    Oh-ishi, T
    Moghaddam, A
    Wang, F
    Tosato, G
    BLOOD, 1998, 91 (06) : 2085 - 2091
  • [24] Role of Virus-Specific T Cell Therapy for Cytomegalovirus and BK Infections in Kidney Transplant Recipients
    Parajuli, Sandesh
    Jorgenson, Margaret
    Meyers, Ross O.
    Djamali, Arjang
    Galipeau, Jacques
    KIDNEY360, 2021, 2 (05): : 905 - 915
  • [25] EPSTEIN-BARR-VIRUS (EBV)-RELATED LYMPHOPROLIFERATIVE DISORDER WITH SUBSEQUENT EBV NEGATIVE T-CELL LYMPHOMA
    TAO, Q
    SRIVASTAVA, G
    LOKE, SL
    LIANG, RHS
    LIU, YT
    HO, FCS
    INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (01) : 33 - 39
  • [26] DEFECTIVE EPSTEIN-BARR VIRUS (EBV)-SPECIFIC T-CELL IMMUNITY IN X-LINKED LYMPHOPROLIFERATIVE SYNDROME
    HARADA, S
    SAKAMOTO, K
    SEELEY, JK
    PURTILO, DT
    FEDERATION PROCEEDINGS, 1982, 41 (03) : 418 - 418
  • [27] Epstein-Barr Virus (EBV)-specific T cells as a diagnostic marker for the individual EBV-specific immune response after pediatric kidney transplantation
    Ahlenstiel-Grunow, Thurid
    Pape, Lars
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [28] IDENTIFICATION OF TARGET ANTIGENS FOR THE HUMAN CYTOTOXIC T-CELL RESPONSE TO EPSTEIN-BARR-VIRUS (EBV) - IMPLICATIONS FOR THE IMMUNE CONTROL OF EBV-POSITIVE MALIGNANCIES
    MURRAY, RJ
    KURILLA, MG
    BROOKS, JM
    THOMAS, WA
    ROWE, M
    KIEFF, E
    RICKINSON, AB
    JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (01): : 157 - 168
  • [29] Prospective follow-up of Epstein-Barr virus (EBV) load in kidney transplant recipients by semiquantitative PCR
    Frias, C
    Lauzurica, R
    Bayès, B
    Hernández, A
    Romero, R
    Arnal, J
    Bonet, J
    Ausina, V
    TRANSPLANTATION, 2001, 71 (01) : S2 - S2
  • [30] Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients
    Nakid-Cordero, Cecilia
    Arzouk, Nadia
    Gauthier, Nicolas
    Tarantino, Nadine
    Larsen, Martin
    Choquet, Sylvain
    Burrel, Sonia
    Autran, Brigitte
    Vieillard, Vincent
    Guihot, Amelie
    PLOS ONE, 2019, 14 (10):
12345